From The Editor
-
Krystal Biotech's Side Business: Gene-Based Aesthetics
11/1/2023
Krystal Biotech's side business is an aesthetics company, Jeune Aesthetics, that uses the same platform and viral vector as Krystal to deliver collagen genes to consumers seeking aesthetic improvement.
-
A Family Affair
11/1/2023
For Krish and Suma Krishnan, the husband-and-wife leadership team at Krystal Biotech, bringing work home, and bringing home to work, is inevitable. A larger shared goal smooths the edges.
-
Too Much Talk About Technology
10/2/2023
To adopt and use new technology effectively, leaders should focus on people and their problems, not the technology itself, according to former Google executive turned biotech CEO.
-
The L Word
9/1/2023
As buzzy development areas buckle down to face the realities of strict regulations, financial demands, and specific unmet needs, the language leaders use to describe their efforts can help, or hurt.
-
A Measure Of Improvement Needed
8/1/2023
New and improved ways of measuring disease symptoms and responses to therapy must overcome established forms of measurement used for regulatory approval.
-
More Than A Seat At The Table
7/3/2023
Bringing different perspectives together is important when debating industry policies, but the middle ground can still be allusive.
-
More Transparency, To A Point
6/1/2023
New salary transparency laws are being enacted by a growing number of states, and more transparency is needed to address existing inequities. Is it possible to be too transparent?
-
The Growing Appetite For Obesity Drugs
4/3/2023
New obesity drugs with unprecedented efficacy are coming into the market. Can they turn the tide in the global obesity epidemic?
-
Commercialization Or Bust?
3/1/2023
If you’re a biotech in the earlier stages of clinical development, is it now incumbent upon leadership to build out the capabilities necessary for regulatory submission and commercialization, in case the right deal doesn’t materialize?
-
Choosing Your Battles
2/1/2023
Should business leaders speak out on the social and political issues that intermingle with the buying and selling of goods and services? Opinions vary … widely.